Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron vs Ondansetron for PONV in ERCP
NCT04576390Phase 4Unknown
- Sponsor
- Theodor Bilharz Research Institute
- Start
- Oct 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of palonosetron in postoperative nausea and vomiting (PONV), sponsored by Theodor Bilharz Research Institute. Status: unknown.
02
Drugs
palonosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT04576390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04576390.